154 related articles for article (PubMed ID: 15577676)
1. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma.
Deyrup AT; Althof P; Zhou M; Morgan M; Solomon AR; Bridge JA; Weiss SW
Am J Surg Pathol; 2004 Dec; 28(12):1579-86. PubMed ID: 15577676
[TBL] [Abstract][Full Text] [Related]
2. Paraganglioma-like dermal melanocytic tumor.
Thyvalappil A; Sudhamani B; Kizhakkethara G; Sridharan R; Kunjan R
Indian J Dermatol; 2015; 60(1):80-1. PubMed ID: 25657403
[TBL] [Abstract][Full Text] [Related]
3. Compound Clear Cell Sarcoma of the Skin-A Potential Diagnostic Pitfall: Report of a Series of 4 New Cases and a Review of the Literature.
Luzar B; Billings SD; de la Fouchardiere A; Pissaloux D; Alberti L; Calonje E
Am J Surg Pathol; 2020 Jan; 44(1):21-29. PubMed ID: 31688004
[TBL] [Abstract][Full Text] [Related]
4. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
5. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.
Zembowicz A; Carney JA; Mihm MC
Am J Surg Pathol; 2004 Jan; 28(1):31-40. PubMed ID: 14707861
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.
Hantschke M; Mentzel T; Rütten A; Palmedo G; Calonje E; Lazar AJ; Kutzner H
Am J Surg Pathol; 2010 Feb; 34(2):216-22. PubMed ID: 20087159
[TBL] [Abstract][Full Text] [Related]
7. Primary paraganglioma-like dermal melanocytic tumor with local recurrence: a case report.
Zhang C; Chen C; Hu H; Yan X
Int J Clin Exp Pathol; 2018; 11(5):2875-2878. PubMed ID: 31938410
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
9. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
10. Meyerson Phenomenon as a Component of Melanoma in situ.
Sezer E; Özturk Durmaz E; Çetin E; Şahin S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
[TBL] [Abstract][Full Text] [Related]
11. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge.
Perron E; Pissaloux D; Charon Barra C; Karanian M; Lamant L; Parfait S; Alberti L; de la Fouchardière A
Am J Surg Pathol; 2018 May; 42(5):595-603. PubMed ID: 29635259
[TBL] [Abstract][Full Text] [Related]
13. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
14. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
15. Large plaque-type blue nevus with subcutaneous cellular nodules.
Busam KJ; Woodruff JM; Erlandson RA; Brady MS
Am J Surg Pathol; 2000 Jan; 24(1):92-9. PubMed ID: 10632492
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of blue nevi and related dermal melanocytic proliferations.
Maize JC; McCalmont TH; Carlson JA; Busam KJ; Kutzner H; Bastian BC
Am J Surg Pathol; 2005 Sep; 29(9):1214-20. PubMed ID: 16096412
[TBL] [Abstract][Full Text] [Related]
17. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]